The invention discloses methods and materials for the utilization of chemically modified oligonucleotides in the treatment of drug-resistant bacterial infections including drug-resistant tuberculosis.

A invenção divulga métodos e materiais para a utilização de oligonucleotides quimicamente modificados no tratamento de infecções bacterianas drug-resistant including o tuberculosis drug-resistant.
 
Web www.patentalert.com

< (none)

< Method for the manufacture of amino group containing support matrices, support matrices prepared by the method, and use of the support matrices

> Nucleosidic and non-nucleosidic folate conjugates

> (none)
~ 00023